PDF) WTX101 in patients newly diagnosed with Wilson disease: final

Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study - The Lancet Gastroenterology & Hepatology

Exploring the potential of trientine tetrahydrochloride in the treatment of Wilson disease - ScienceDirect

Chelation therapy in liver diseases of childhood: Current status and response

IJMS, Free Full-Text

PDF) Wilson disease: more complex than just simply a copper overload condition?—a narrative review

Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent

Diagnosis - Wilson Disease Association

Full article: Metabolic disposition of WTX101 (bis-choline tetrathiomolybdate) in a rat model of Wilson disease

PDF) Wilson's Disease: An Update on the Diagnostic Workup and Management

Bis-choline tetrathiomolybdate prevents copper-induced blood–brain barrier damage

Wilsons Disease Treatment Market Innovative Treatments, Success Milestones by Top Players and Forecasts by 2026

Updates on Wilson disease : Clinical Liver Disease

Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent

Inorganics, Free Full-Text